Alan L. Pehrson

Brexpiprazole I: In Vitro and In Vivo Characterization of a Novel Serotonin-Dopamine Activity Modulator

Kenji Maeda, Haruhiko Sugino, Hitomi Akazawa et al. · Journal of Pharmacology and Experimental Therapeutics · 2014 · 347 citations

Pharmacological Effects of Lu AA21004: A Novel Multimodal Compound for the Treatment of Major Depressive Disorder

Arne Mørk, Alan L. Pehrson, Lise T. Brennum et al. · Journal of Pharmacology and Experimental Therapeutics · 2011 · 265 citations

Lu AA21004, a novel multimodal antidepressant, produces regionally selective increases of multiple neurotransmitters—A rat microdialysis and electrophysiology study

Alan L. Pehrson, Thomas I.F.H. Cremers, Cécile Betry et al. · European Neuropsychopharmacology · 2012 · 155 citations

Lu Aa21004, Psychiatry, Medicine +11

Vortioxetine dose-dependently reverses 5-HT depletion-induced deficits in spatial working and object recognition memory: A potential role for 5-HT1A receptor agonism and 5-HT3 receptor antagonism

Kristian Gaarn du Jardin, Jesper Bornø Jensen, Connie Sánchez et al. · European Neuropsychopharmacology · 2013 · 132 citations · Full text

Chronic Vortioxetine Administration, Neuropsychology, Brain Function +19

Antidepressant and anxiolytic potential of the multimodal antidepressant vortioxetine (Lu AA21004) assessed by behavioural and neurogenesis outcomes in mice

Jean‐Philippe Guilloux, Indira Mendez‐David, Alan L. Pehrson et al. · Neuropharmacology · 2013 · 112 citations · Full text

Psychotropic Medication, Psychopharmacology, Pharmacotherapy +17